Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the ...

The Food and Drug Administration is requiring Pfizer and Moderna to expand warnings on the labels of their COVID-19 vaccines ...

The FDA approved three natural food additives. Food and nutrition experts share what that means for families and our food ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

Recent FDA updates in the areas of cardiac intervention, hypertension and arrhythmia disorders expand the pool of available ...

Only one fourth of sunscreens on store shelves in the United States deliver safe and effective protection against the harmful rays of the sun, according to an annual report which analyzed more than 2, ...

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

The agency is planning a new review process that could result in ingredient bans or additional labeling requirements, ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...